Cargando…
Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
OBJECTIVE: Cannabinoid receptor 1 (CB1) is localized in the central nervous system and in peripheral tissues involved in energy metabolism control. However, CB1 receptors are also expressed at low level within the glomeruli, and the aim of this study was to investigate their potential relevance in t...
Autores principales: | Barutta, Federica, Corbelli, Alessandro, Mastrocola, Raffaella, Gambino, Roberto, Di Marzo, Vincenzo, Pinach, Silvia, Rastaldi, Maria Pia, Perin, Paolo Cavallo, Gruden, Gabriella |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844813/ https://www.ncbi.nlm.nih.gov/pubmed/20068137 http://dx.doi.org/10.2337/db09-1336 |
Ejemplares similares
-
Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy
por: Barutta, Federica, et al.
Publicado: (2011) -
Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy
por: Barutta, Federica, et al.
Publicado: (2013) -
Effect of the Monocyte Chemoattractant Protein-1/CC Chemokine Receptor 2 System on Nephrin Expression in Streptozotocin-Treated Mice and Human Cultured Podocytes
por: Tarabra, Elena, et al.
Publicado: (2009) -
Mechanisms of podocyte injury and implications for diabetic nephropathy
por: Barutta, Federica, et al.
Publicado: (2022) -
Response to Comment on: Gruden et al. Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care 2012;35:1598–1604
por: Gruden, Gabriella, et al.
Publicado: (2012)